guanidinopropionic acid has been researched along with Disease Models, Animal in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beal, MF; Calingasan, NY; Chaturvedi, RK; Hennessey, T; Johri, A; Yang, L | 1 |
Choi, SY; Kang, TC; Kim, DW; Kim, JE; Kwon, OS; Ryu, HJ; Song, HK; Yeo, SI | 1 |
de Souza, CJ; Meglasson, MD; Robinson, DD; Wilson, JM; Wyse, BM; Yu, JH | 1 |
Friedrich, J; Gwathmey, JK; Ingwall, JS; Liao, R; Nascimben, L | 1 |
Dienesch, C; Horn, M; Neubauer, S; Remkes, H; Strömer, H | 1 |
5 other study(ies) available for guanidinopropionic acid and Disease Models, Animal
Article | Year |
---|---|
Impairment of PGC-1alpha expression, neuropathology and hepatic steatosis in a transgenic mouse model of Huntington's disease following chronic energy deprivation.
Topics: Adenosine Triphosphate; AMP-Activated Protein Kinases; Animals; Blotting, Western; Cerebral Cortex; Corpus Striatum; Disease Models, Animal; DNA, Mitochondrial; Energy Metabolism; Fatty Liver; Gene Expression; Guanidines; Humans; Huntington Disease; Immunohistochemistry; Ion Channels; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Transgenic; Mitochondrial Proteins; Nuclear Respiratory Factor 1; Peripheral Nervous System Diseases; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Propionates; Reverse Transcriptase Polymerase Chain Reaction; Trans-Activators; Transcription Factors; Uncoupling Protein 1 | 2010 |
Effects of creatine and β-guanidinopropionic acid and alterations in creatine transporter and creatine kinases expression in acute seizure and chronic epilepsy models.
Topics: Acute Disease; Animals; CA1 Region, Hippocampal; Chronic Disease; Creatine; Creatine Kinase; Disease Models, Animal; Epilepsy; Guanidines; Immunohistochemistry; Male; Membrane Transport Proteins; Propionates; Rats; Rats, Sprague-Dawley | 2010 |
Antihyperglycemic action of guanidinoalkanoic acids: 3-guanidinopropionic acid ameliorates hyperglycemia in diabetic KKAy and C57BL6Job/ob mice and increases glucose disappearance in rhesus monkeys.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Gluconeogenesis; Glucose; Glycogen; Guanidines; Hyperglycemia; Insulin; Insulin Resistance; Intestinal Absorption; Liver Glycogen; Macaca mulatta; Male; Metformin; Mice; Mice, Inbred C57BL; Mice, Obese; Muscles; Propionates; Structure-Activity Relationship | 1993 |
Decreased energy reserve in an animal model of dilated cardiomyopathy. Relationship to contractile performance.
Topics: Adenosine Triphosphate; Animals; Cardiomyopathy, Dilated; Creatine; Creatine Kinase; Disease Models, Animal; Energy Metabolism; Furazolidone; Guanidines; Heart; In Vitro Techniques; Myocardial Contraction; Myocardium; Propionates; Reference Values; Time Factors; Turkeys | 1996 |
Chronic phosphocreatine depletion by the creatine analogue beta-guanidinopropionate is associated with increased mortality and loss of ATP in rats after myocardial infarction.
Topics: Adenosine Triphosphate; Animals; Blood Flow Velocity; Body Weight; Chronic Disease; Coronary Circulation; Coronary Vessels; Disease Models, Animal; Guanidines; Heart; Heart Rate; Homeostasis; In Vitro Techniques; Ligation; Magnetic Resonance Spectroscopy; Myocardial Infarction; Organ Size; Phosphocreatine; Phosphorus Isotopes; Propionates; Rats; Rats, Wistar; Survival Rate; Ultrasonography; Ventricular Function, Left | 2001 |